Please login to read the full article.
Scrip Regulatory Affairs
US FDA explains processes to appeal against decisions of its device staff
30 December 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA's device ombudsman reports 11% increase in contacts in 2011
- US FDA consults on fulfilling obligations for device post-market surveillance studies
- FDA report questions whether US rules can ensure quality of marketed medical devices
- US FDA consults on creating external expert network for emerging medical devices
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
